Phathom Pharmaceuticals, Inc. (PHAT): 7 insider purchases in the last two years (2 opportunistic).
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| May 23, 2025 | Topper James N Director | 3,780 | $3.86 | $14.6K | no history |
| May 15, 2025 | Topper James N Director | 7,420 | $3.30 | $24.5K | no history |
| May 13, 2025 | Topper James N Director | 48,203 | $3.17 | $152.8K | no history |
| May 8, 2025 | Parikh Asit Director | 10,000 | $2.50 | $25.0K | opportunistic |
| Mar 17, 2025 | Parikh Asit Director | 10,000 | $4.42 | $44.2K | opportunistic |
| Dec 16, 2024 | Parikh Asit Director | 10,000 | $8.12 | $81.2K | no history |
| Dec 16, 2024 | Karbe Frank Director | 12,500 | $7.93 | $99.1K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.